Pyrazinamide Tablets

Pyrazinamide Tablets

Product Name : Pyrazinamide Tablets

Trade Name : Pyzina,Rifater, Tebrazid

Available Strength : 250 mg, 500 mg, 750 mg ,1000 mg

Available Combination : Pyrazinamide+Rifampin+Isoniazid+ Ethambutol tablet

Packing : 10 X 10 Tablets/Box

Pack Insert/Leaflet : Yes

Therapeutic use : Antibiotic, Antituberculosis

Production Capacity : 10 million tablet/month

Description

Pyrazinamide Tablet is a medicine that is used for the treatment of Tuberculosis and other conditions.
Pyrazinamide Tablet contains Pyrazinamide as an active ingredient.
Pyrazinamide Tablet works by preventing growth of bacteria that causes tuberculosis.
Detailed information related to Pyrazinamide Tablet’s uses, composition, dosage, side effects and reviews is listed below.

Pyrazinamide Tablet Uses

Pyrazinamide Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

  • Tuberculosis

Pyrazinamide Tablet Working, Mechanism of Action and Pharmacology

Pyrazinamide Tablet improves the patient’s condition by performing the following functions:

  • Preventing growth of bacteria that causes tuberculosis.

Pyrazinamide Tablet – Composition and Active Ingredients

Pyrazinamide Tablet is composed of the following active ingredients (salts)

  • Pyrazinamide (500 MG)

Please note that this medicine may be available in various strengths for each active ingredient listed above.

Pyrazinamide Tablet – Side-effects

The following is a list of possible side-effects that may occur from all constituting ingredients of Dextromethorphan Chlorpheniramine Maleate & Phenylephrine Syrup Syrup. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.

  • Itching Of Skin
  • Enlarged Liver
  • Pain While Urination
  • Worsening Of Stomach Or Intestinal Ulcers
  • Feeling Of Discomfort
  • Abnormal Liver Function Tests

Pyrazinamide Tablet – Precautions & How to Use

Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.

  • Avoid alcoholic beverages
  • Do not double the dose to make up for the missed dose
  • Do not have any immunizations or vaccinations while using this drug
  • Do not stop taking this drug suddenly
  • Planning to get pregnant
  • Regularly monitor liver function and blood uric acid levels during treatment

Additional Information

The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:

ASIA: Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Afghanistan, Israel, Jordan, Pakistan, Russia, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth..

AFRICA: South Africa, Uganda, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, and so forth.

NORTH & SOUTH AMERICA: Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela, USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Brazil, Bahamas, Ecuador, and so forth .

EUROPE: France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Austria, Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

OCEANIA: Fiji, Australia, New Zealand, and so forth.

Leave a Reply

Your email address will not be published.